Hyperoxia exaggerates bacterial dissemination and lethality in Pseudomonas aeruginosa pneumonia

Area of Science:

• Microbiology
• Pulmonology
• Pharmacology

Background:

• Pseudomonas aeruginosa pneumonia is a severe infection.
• Hyperoxia (high oxygen levels) can exacerbate lung injury.
• Macrolides are antibiotics with potential anti-inflammatory effects.

Purpose of the Study:

• To investigate the impact of hyperoxia on P. aeruginosa pneumonia lethality.
• To evaluate the protective role of macrolides against hyperoxia-induced exacerbation.
• To elucidate the mechanisms underlying hyperoxia's effect on bacterial virulence and host response.

Main Methods:

• Mice models of P. aeruginosa pneumonia were exposed to normoxia or hyperoxia.
• Bacterial load in lungs and liver was quantified.
• Cytotoxicity of bacterial culture supernatants on alveolar epithelial cells was assessed.
• The effect of macrolides (azithromycin) on bacterial cytotoxicity and dissemination was evaluated in vitro and in vivo.

Main Results:

• Sub-lethal hyperoxia significantly increased mortality in mice with P. aeruginosa pneumonia.
• Hyperoxia led to increased bacterial dissemination to the liver, not lungs.
• Bacterial supernatants exhibited cytotoxicity towards alveolar epithelial cells, enhanced by hyperoxia.
• Azithromycin reduced bacterial cytotoxicity and prevented extra-pulmonary bacterial spread, improving survival.

Conclusions:

• Hyperoxia acts as a cofactor, accelerating lethality in P. aeruginosa pneumonia by promoting bacterial dissemination.
• Macrolides, particularly azithromycin, demonstrate therapeutic potential in mitigating hyperoxia-induced exacerbation of P. aeruginosa pneumonia.
• Targeting bacterial dissemination and epithelial cell damage may be key strategies for treating pneumonia in hyperoxic environments.